RARE

ULTRAGENYX PHARMACEUTICAL INC

Healthcare | Mid Cap

-$1.28

EPS Forecast

$149.8

Revenue Forecast

Announcing earnings for the quarter ending 2024-12-31 soon
ALKSAlkermes PlcALNYAlnylam Pharmaceuticals IncBMRNBiomarin Pharmaceutical IncIONSIonis Pharmaceuticals IncJAZZJazz Pharmaceuticals PlcNKTRNektar TherapeuticsPAHCPhibro Animal Health CorpSAGESage Therapeutics IncSRPTSarepta Therapeutics Inc